Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation
Top Cited Papers
Open Access
- 14 March 2006
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 118 (11) , 2803-2808
- https://doi.org/10.1002/ijc.21728
Abstract
Changes in oligosaccharide structures have been reported in certain types of malignant transformations and, thus, could be used for tumor markers in certain types of cancer. In the case of pancreatic cancer cell lines, a variety of fucosylated proteins are secreted into their conditioned media. To identify fucosylated proteins in the serum of patients with pancreatic cancer, we performed western blot analyses using Aleuria Aurantica Lectin (AAL), which is specific for fucosylated structures. An ∼40 kD protein was found to be highly fucosylated in pancreatic cancer and an N‐terminal analysis revealed that it was the β chain of haptoglobin. While the appearance of fucosylated haptoglobin has been reported in other diseases such as hepatocellular carcinoma, liver cirrhosis, gastric cancer and colon cancer, the incidence was significantly higher in the case of pancreatic cancer. Fucosylated haptoglobin was observed more frequently at the advanced stage of pancreatic cancer and disappeared after an operation. A mass spectrometry analysis of haptoglobin purified from the serum of patients with pancreatic cancer and the medium from a pancreatic cancer cell line, PSN‐1, showed that the α 1‐3/α 1‐4/α 1‐6 fucosylation of haptoglobin was increased in pancreatic cancer. When a hepatoma cell line, Hep3B, was cultured with the conditioned media from pancreatic cancer cells, haptoglobin secretion was dramatically increased. These findings suggest that fucosylated haptoglobin could serve as a novel marker for pancreatic cancer. Two possibilities were considered in terms of the fucosylation of haptoglobin. One is that pancreatic cancer cells, themselves, produce fucosylated haptoglobin; the other is that pancreatic cancer produces a factor, which induces the production of fucosylated haptoglobin in the liver.Keywords
This publication has 20 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- The impact of different types of surgery in pancreatic cancerEuropean Journal of Surgical Oncology, 1999
- Increase of rat colon carcinoma cells tumorigenicity by α(l–2) fucosyltransferase gene transfectionGlycobiology, 1997
- Prognostic significance of Lens culinaris agglutinin A-reactive alpha- fetoprotein in small hepatocellular carcinomasGastroenterology, 1996
- HaptoglobinPublished by Springer Nature ,1995
- Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1994
- The glycosylation of haptoglobin in rheumatoid arthritisClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancerCancer Letters, 1992
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate AntigensAdvances in Cancer Research, 1989
- Primary structures of human alpha-fetoprotein and its mRNA.Proceedings of the National Academy of Sciences, 1983